Androgen Receptor Expression and Bicalutamide Antagonize Androgen Receptor Inhibit β-Catenin Transcription Complex in Estrogen Receptor-Negative Breast Cancer

Androgen Receptor Expression and Bicalutamide Antagonize Androgen Receptor Inhibit β-Catenin Transcription Complex in Estrogen Receptor-Negative Breast Cancer

Background/Aims: Little is known about the potential mechanism of action for androgen receptor (AR) targeting treatment in estrogen receptor (ER)-negative breast cancer. This study aimed to evaluate AR status and its prognosis in four breast cancer subtypes. Bicalutamide has been identified as an AR...

Full description

Bibliographic Details
Main Authors: Rui Huang, Jiguang Han, Xiaoshuan Liang, Shanshan Sun, Yongdong Jiang, Bingshu Xia, Ming Niu, Dalin Li, Jian Zhang, Shuo Wang, Wei Wei, Qing Liu, Wei Zheng, Guoqiang Zhang, Yanni Song, Da Panga
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2017-10-01
Series:Cellular Physiology and Biochemistry
Subjects:
Breast cancer
Prognosis
Antagonize
Estrogen receptor-negative
Bicalutamide
Androgen receptor-positive
Online Access:https://www.karger.com/Article/FullText/484300

Internet

https://www.karger.com/Article/FullText/484300

Similar Items